Results 11 to 20 of about 156,286 (266)

Estimating Hazard Function and Survival Analysis of Tuberculosis Patients in Erbil city

Tikrit Journal of Administrative and Economic Sciences, 2021
The study aimed to estimate the effects of prognostic factors on tuberculosis (TB) survival. Two models have been studied (Logistic model and Cox regression models) in survival analysis.
Kurdistan Ibrahim Mawlood, Hogr Muhammed Qader   +1 more
doaj   +1 more source

Statin use and all-cause and cancer mortality: BioBank Japan cohort

Journal of Epidemiology, 2017
Background: Statins are the first-line agents used to treat patients with high serum low-density lipoprotein cholesterol levels, thus reducing the risk of death from arterial sclerotic cardiovascular disease; however, little is known about the effects of
Hiroshi Yokomichi
doaj   +1 more source

Survival of silver diamine fluoride among patients treated in community dental clinics: a naturalistic study

BMC Oral Health, 2021
Background Silver diamine fluoride (SDF) is a minimally-invasive preventive service used in the U.S. to avert and arrest caries since 2014. No studies document survival outcomes based in real world delivery.
Sarah E. Raskin, Eric P. Tranby, Sharity Ludwig, Ilya Okunev, Julie Frantsve-Hawley, Sean Boynes   +5 more
doaj   +1 more source

Real-world treatment patterns and outcomes among individuals receiving first-line pembrolizumab therapy for recurrent/metastatic head and neck squamous cell carcinoma

Frontiers in Oncology, 2023
BackgroundPembrolizumab, a PD-1 immune checkpoint inhibitor, is approved as first-line (1L) treatment for recurrent or metastatic head and neck squamous cell carcinoma (R/M HNSCC) as monotherapy or in combination with platinum and 5-fluorouracil ...
Christopher M. Black, Glenn J. Hanna, Liya Wang, Karthik Ramakrishnan, Daisuke Goto, Vladimir Turzhitsky, Gleicy M. Hair   +6 more
doaj   +1 more source

Estimation of the Distribution of Duration of Breastfeeding from Cross-Sectional Data: Some Methodological Issue.

Journal of Biostatistics and Epidemiology, 2021
Background: Duration of breastfeeding is an important health indicator of mother and child. There are various indirect epidemiological methods available to estimate the duration of breastfeeding from cross sectional data.
Anup Kumar, Sachin Kumar, Jai Kishun, Uttam Singh, Pushpraj Pushpraj   +4 more
doaj   +1 more source

Kaplan-Meier Survival Analysis: Practical Insights for Clinicians

Acta Médica Portuguesa
This article aims to provide a guide that will help healthcare professionals and clinical researchers from all fields that deal with Kaplan-Meier curves.
António Pedro Gomes, Bruna Costa, Rita Marques, Vitor Nunes, Constança Coelho   +4 more
doaj   +1 more source

Doubly robust estimator of risk in the presence of censoring dependent on time-varying covariates: application to a primary prevention trial for coronary events with pravastatin

BMC Medical Research Methodology, 2020
Background In the presence of dependent censoring even after stratification of baseline covariates, the Kaplan–Meier estimator provides an inconsistent estimate of risk.
Takuya Kawahara, Tomohiro Shinozaki, Yutaka Matsuyama   +2 more
doaj   +1 more source

Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis

BMC Medical Research Methodology, 2016
Background The difference in restricted mean survival time ( rmstD t ∗ $$ rmstD\left({t}^{\ast}\right) $$ ), the area between two survival curves up to time horizon t ∗ $$ {t}^{\ast } $$ , is often used in cost-effectiveness analyses to estimate the ...
Béranger Lueza, Federico Rotolo, Julia Bonastre, Jean-Pierre Pignon, Stefan Michiels   +4 more
doaj   +1 more source

Time-to-event analysis

Perspectives in Clinical Research
Survival analysis (or time-to-event analysis) deals with data where the outcome of interest is the length of time until the occurrence of an event. This type of analysis is unique because the event may not occur in all participants (known as censoring ...
Priya Ranganathan, Vishal Deo, C. S. Pramesh   +2 more
doaj   +1 more source

Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High‐Risk Neuroblastoma: A Multi‐Institutional Retrospective Study

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Chemoimmunotherapy with irinotecan, temozolomide, and dinutuximab (I/T/DIN) has emerged as first‐line therapy for relapsed/refractory (r/r) high‐risk neuroblastoma (HRNB) in North America. Topotecan and cyclophosphamide (T/C) are often used in combination with dinutuximab in the setting of lack of response, progression, or incomplete ...
Benjamin J. Lerman, Madeleine King, Rajen Mody, Sara‐Jane Onyeama, Araz Marachelian, Thomas Cash, Sara M. Federico, Meaghan Granger, Ami V. Desai, Suzanne Shusterman, Jennifer H. Foster, Elizabeth Sokol, Chelsee Greer, Keri Streby, Holly J. Meany, Kieuhoa T. Vo, Margaret E. Macy, Rochelle Bagatell   +17 more
wiley   +1 more source